Most fibroadenomas grow slowly, averaging about 1 inch (2.5 cm) in size. Many stay stable for years, and some actually shrink on their own. But growth speed varies widely depending on the type of fibroadenoma, your age, and hormonal changes like pregnancy.
Typical Growth Rate for Simple Fibroadenomas
Simple fibroadenomas, which make up the vast majority of cases, tend to grow gradually over months to years rather than weeks. There’s no single “speed” that applies to everyone. Some stay the same size for years on imaging, while others slowly enlarge. When growth does happen, it’s usually modest enough that it’s tracked with ultrasound every six months to see whether meaningful change has occurred.
The benchmark clinicians use is a 20% increase in size on repeat imaging. If a fibroadenoma grows by more than 20% between scans, it gets reclassified as something that warrants a closer look, typically a biopsy. Below that threshold, the standard approach is continued monitoring. This means that for most people, a fibroadenoma that was 2 cm six months ago and is now 2.2 cm would still fall within the “watch and wait” range.
Giant and Juvenile Fibroadenomas Grow Faster
Not all fibroadenomas follow the slow-growth pattern. Giant fibroadenomas, defined as those larger than 5 cm (about 2 inches), can grow quickly and sometimes reach 10 cm or more. These account for only about 0.5 to 2% of fibroadenomas in adolescents, but when they occur, the growth can be rapid enough to visibly change the shape of the breast.
Juvenile fibroadenomas, which occur in teenagers and young women, are a related subtype that tends to be more cellular and faster-growing. In one study published in the American Journal of Roentgenology, juvenile fibroadenomas at initial presentation ranged from 5 to 12.5 cm, with an average size of about 8.3 cm. By comparison, simple fibroadenomas in the same study averaged 3.3 cm. Juvenile fibroadenomas can also trigger a fibrotic reaction in developing breast tissue, which may distort the breast beyond the size of the mass itself.
Hormones Drive Most Growth Changes
Fibroadenomas are sensitive to estrogen, which is why their behavior often tracks with hormonal shifts throughout your life. During pregnancy, fibroadenomas commonly enlarge, sometimes noticeably. This isn’t a sign that something has gone wrong. It reflects the surge in estrogen and other hormones that also cause general breast tissue changes during pregnancy.
Hormone replacement therapy can have a similar effect in postmenopausal women, potentially stimulating growth in fibroadenomas that had been stable or shrinking. On the other end of the spectrum, fibroadenomas often shrink after menopause as estrogen levels drop. Some eventually calcify, becoming dense and sometimes visible as bright spots on a mammogram. This calcification is harmless and is actually a sign the fibroadenoma is becoming less active.
Some Fibroadenomas Shrink or Disappear
It’s worth knowing that growth isn’t inevitable. Some fibroadenomas shrink over time without any treatment. This is especially common after menopause, but it can happen at any age. Complete spontaneous resolution, where the fibroadenoma disappears entirely, does occur, though it’s less common than simply getting smaller. If you’re in a monitoring period and your fibroadenoma is stable or shrinking, that’s a reassuring pattern.
How Growth Is Monitored
The standard monitoring schedule for a fibroadenoma with typical imaging features is ultrasound every six months for two years. After that, if the mass has been stable, you return to routine screening. This timeline is designed to catch any meaningful growth early. The American College of Radiology considers this short-term follow-up a reasonable alternative to biopsy for solid masses that look like fibroadenomas on imaging.
Complex fibroadenomas, which contain features like cysts or other tissue changes, follow the same monitoring guidelines as simple ones in the absence of atypical findings. A study in the American Journal of Roentgenology found that complex fibroadenomas can be managed with the same surveillance approach: imaging every six months for two years, then annually.
When Growth Triggers Further Action
Three situations generally prompt a shift from monitoring to intervention. The first is size: fibroadenomas larger than 2.5 cm often warrant a surgical consultation regardless of growth rate. The second is enlargement on serial imaging over a six-month interval, particularly if it exceeds that 20% threshold. The third is symptoms, whether that’s significant pain or emotional distress from having the mass.
If a biopsy shows concerning features like atypical cells or increased stromal cellularity (essentially, the tissue looks more active than a typical fibroadenoma), excision is recommended even if the growth rate has been slow. A fibroadenoma that’s growing on every scan, even modestly, is treated differently from one that enlarged once and then stabilized. The pattern of growth matters as much as the speed.